The ENT Suture market exhibits strong market attractiveness driven by rising incidence of chronic ENT disorders, surgical volume growth, and advancements in minimally invasive procedures. The competitive intensity remains moderate, with established players dominating premium segments while niche innovators target specialized applications. The long-term outlook is optimistic, supported by aging populations and expanding healthcare access in emerging economies. The innovation landscape is dynamic, focusing on biocompatible materials, antimicrobial coatings, and suture designs that enhance healing precision. However, demand–supply balance faces pressure from raw material volatility and regulatory delays in product approvals. Decision-makers should prioritize risk mitigation around reimbursement policy shifts, supply chain disruptions, and technological obsolescence to capitalize on the ENT Suture market outlook.